These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1280326)

  • 1. The SH2- and SH3-containing Nck protein transforms mammalian fibroblasts in the absence of elevated phosphotyrosine levels.
    Chou MM; Fajardo JE; Hanafusa H
    Mol Cell Biol; 1992 Dec; 12(12):5834-42. PubMed ID: 1280326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SH2 and SH3 domain-containing Nck protein is oncogenic and a common target for phosphorylation by different surface receptors.
    Li W; Hu P; Skolnik EY; Ullrich A; Schlessinger J
    Mol Cell Biol; 1992 Dec; 12(12):5824-33. PubMed ID: 1333047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crk-phosphotyrosine-dependent interactions in vitro.
    Birge RB; Fajardo JE; Mayer BJ; Hanafusa H
    J Biol Chem; 1992 May; 267(15):10588-95. PubMed ID: 1375224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of domains of the v-crk oncogene product sufficient for association with phosphotyrosine-containing proteins.
    Matsuda M; Mayer BJ; Hanafusa H
    Mol Cell Biol; 1991 Mar; 11(3):1607-13. PubMed ID: 1705010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SH2/SH3 domain-containing protein Nck is recognized by certain anti-phospholipase C-gamma 1 monoclonal antibodies, and its phosphorylation on tyrosine is stimulated by platelet-derived growth factor and epidermal growth factor treatment.
    Meisenhelder J; Hunter T
    Mol Cell Biol; 1992 Dec; 12(12):5843-56. PubMed ID: 1448108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts.
    Birge RB; Fajardo JE; Reichman C; Shoelson SE; Songyang Z; Cantley LC; Hanafusa H
    Mol Cell Biol; 1993 Aug; 13(8):4648-56. PubMed ID: 7687742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct binding of C-terminal region of p130Cas to SH2 and SH3 domains of Src kinase.
    Nakamoto T; Sakai R; Ozawa K; Yazaki Y; Hirai H
    J Biol Chem; 1996 Apr; 271(15):8959-65. PubMed ID: 8621540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Cbl-Nck and Nck-Pak1 interactions in myeloid FcgammaRII signaling.
    Izadi KD; Erdreich-Epstein A; Liu Y; Durden DL
    Exp Cell Res; 1998 Dec; 245(2):330-42. PubMed ID: 9851874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin-mediated cell adhesion promotes tyrosine phosphorylation of p130Cas, a Src homology 3-containing molecule having multiple Src homology 2-binding motifs.
    Nojima Y; Morino N; Mimura T; Hamasaki K; Furuya H; Sakai R; Sato T; Tachibana K; Morimoto C; Yazaki Y
    J Biol Chem; 1995 Jun; 270(25):15398-402. PubMed ID: 7541040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A casein kinase I activity is constitutively associated with Nck.
    Lussier G; Larose L
    J Biol Chem; 1997 Jan; 272(5):2688-94. PubMed ID: 9006905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and biochemical activity of v-Crk chimeras containing the SH2/SH3 regions of phosphatidylinositol-specific phospholipase C-gamma and Src.
    Matsuda M; Reichman CT; Hanafusa H
    J Virol; 1992 Jan; 66(1):115-21. PubMed ID: 1370084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of multiple SH3 domains of Nck for ligand binding.
    Wunderlich L; Gohér A; Faragó A; Downward J; Buday L
    Cell Signal; 1999 Apr; 11(4):253-62. PubMed ID: 10372803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine.
    Okada M; Howell BW; Broome MA; Cooper JA
    J Biol Chem; 1993 Aug; 268(24):18070-5. PubMed ID: 7688738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor.
    Miyoshi-Akiyama T; Aleman LM; Smith JM; Adler CE; Mayer BJ
    Oncogene; 2001 Jul; 20(30):4058-69. PubMed ID: 11494134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced direct binding of the adapter protein Nck to the GTPase-activating protein-associated protein p62 by epidermal growth factor.
    Tang J; Feng GS; Li W
    Oncogene; 1997 Oct; 15(15):1823-32. PubMed ID: 9362449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple SH2-mediated interactions in v-src-transformed cells.
    Koch CA; Moran MF; Anderson D; Liu XQ; Mbamalu G; Pawson T
    Mol Cell Biol; 1992 Mar; 12(3):1366-74. PubMed ID: 1545818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel ligand for an SH3 domain of the adaptor protein Nck bears an SH2 domain and nuclear signaling motifs.
    Matuoka K; Miki H; Takahashi K; Takenawa T
    Biochem Biophys Res Commun; 1997 Oct; 239(2):488-92. PubMed ID: 9344857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of YRP kinase by v-Src and protein kinase C-mediated signal transduction pathways.
    Scholz G; Felder MP; Hanafusa H
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2592-6. PubMed ID: 7535926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src homology region 2 domains direct protein-protein interactions in signal transduction.
    Moran MF; Koch CA; Anderson D; Ellis C; England L; Martin GS; Pawson T
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8622-6. PubMed ID: 2236073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.